ID16618A - Bahan-bahan estrogen - Google Patents

Bahan-bahan estrogen

Info

Publication number
ID16618A
ID16618A IDP971302A ID971302A ID16618A ID 16618 A ID16618 A ID 16618A ID P971302 A IDP971302 A ID P971302A ID 971302 A ID971302 A ID 971302A ID 16618 A ID16618 A ID 16618A
Authority
ID
Indonesia
Prior art keywords
estrogen
materials
estrogen materials
Prior art date
Application number
IDP971302A
Other languages
English (en)
Inventor
Chris Paul Miller
Michael D Collini
Bach Diah Tran
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of ID16618A publication Critical patent/ID16618A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IDP971302A 1996-04-19 1997-04-17 Bahan-bahan estrogen ID16618A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63397296A 1996-04-19 1996-04-19
US63397696A 1996-04-19 1996-04-19

Publications (1)

Publication Number Publication Date
ID16618A true ID16618A (id) 1997-10-23

Family

ID=27092024

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971302A ID16618A (id) 1996-04-19 1997-04-17 Bahan-bahan estrogen

Country Status (23)

Country Link
EP (1) EP0802184B1 (id)
JP (1) JPH1036347A (id)
KR (1) KR970069986A (id)
CN (1) CN1103756C (id)
AR (1) AR006705A1 (id)
AT (1) ATE219485T1 (id)
AU (1) AU718888B2 (id)
BR (1) BR9701879A (id)
CO (1) CO4950540A1 (id)
CZ (1) CZ293065B6 (id)
DE (1) DE69713441T2 (id)
DK (1) DK0802184T3 (id)
EA (1) EA000815B1 (id)
ES (1) ES2179273T3 (id)
HU (1) HUP9700779A1 (id)
ID (1) ID16618A (id)
IL (1) IL120699A0 (id)
NO (1) NO308214B1 (id)
NZ (1) NZ314595A (id)
PT (1) PT802184E (id)
SK (1) SK282765B6 (id)
TW (1) TW397821B (id)
UA (1) UA47413C2 (id)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6069153A (en) * 1998-05-12 2000-05-30 American Home Products Corporation Indenoindoles and benzocarbazoles as estrogenic agents
ATE339415T1 (de) * 1998-05-12 2006-10-15 Wyeth Corp Benzocarbazol und indenoindole derivate als östrogene agentien
JP2002515431A (ja) * 1998-05-15 2002-05-28 アメリカン・ホーム・プロダクツ・コーポレイション エストロゲンと組み合わせる２−フェニル−１−［４−（２−アミノエトキシ）ベンジルオキシ］インドール
CN1309637A (zh) * 1998-05-15 2001-08-22 美国家用产品公司 包含2－苯基－吲哚化合物和雌激素制剂的组合物
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
AU2004200099B2 (en) * 1998-06-11 2006-11-02 Endorecherche, Inc. Medical Uses of A Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
CA2382683A1 (en) * 1999-09-13 2001-03-22 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-¬4-(2-amin-1-yl-ethoxy)-benzyl|-1h-indol-5-ols
AR030064A1 (es) * 2000-07-06 2003-08-13 Wyeth Corp Metodos para inhibir los efectos uterotroficos de los agentes estrogenicos
US20020022617A1 (en) * 2000-07-06 2002-02-21 American Home Products Corporation Methods for increasing nitric oxide synthase activity
AR029539A1 (es) 2000-07-06 2003-07-02 Wyeth Corp Combinaciones de estatinas y agentes estrogenicos
US6369051B1 (en) 2000-07-06 2002-04-09 American Home Products Corporation Combinations of SSRI and estrogenic agents
WO2002003989A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating sphincter incontinence
US6509332B2 (en) 2000-07-06 2003-01-21 Wyeth Methods of treating excessive intraocular pressure
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
AU2001271784A1 (en) * 2000-07-06 2002-01-21 Wyeth Therapy for prosthesis-related bone degeneration
HK1052877A1 (zh) * 2000-07-06 2003-10-03 Wyeth Ssri与雌激素剂之组合
WO2002003986A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating breast disorders
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
EP1656938A1 (en) 2000-07-06 2006-05-17 Wyeth Combinations of SSRI and estrogenic agents
WO2002003988A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating neuropeptide y-related conditions
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
GEP20053586B (en) * 2000-08-24 2005-07-25 Univ Tennessee Res Corp Selective Androgen Receptor Modulators and Pharmaceutical Compositions Containing the Same
US6962928B2 (en) 2001-05-22 2005-11-08 Eli Lilly And Company Tetrahydroquinoline derivatives for the inhibition of osteoporosis, estrogen dependent breast cancer, endometriosis and uterine fibrosis
JP2004531562A (ja) 2001-05-22 2004-10-14 イーライ・リリー・アンド・カンパニー ２−置換１，２，３，４−テトラヒドロキノリンおよびその誘導体、組成物ならびに方法
US7683052B2 (en) 2004-04-07 2010-03-23 Wyeth Crystalline polymorph of bazedoxifene acetate
US7683051B2 (en) 2004-04-07 2010-03-23 Wyeth Crystalline polymorph of bazedoxifene acetate
JP2007532556A (ja) 2004-04-08 2007-11-15 ワイス 選択的エストロゲン受容体調節剤としてのアスコルビン酸バゼドキシフェン
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EA200700243A1 (ru) 2004-07-14 2007-08-31 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы лечения гепатита с
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008507518A (ja) 2004-07-22 2008-03-13 ピーティーシー セラピューティクス，インコーポレーテッド Ｃ型肝炎を治療するためのチエノピリジン
CN106038572A (zh) 2004-10-20 2016-10-26 恩多研究公司 性甾体前体单独或与选择性雌激素受体调节剂联合用于预防和治疗绝经后女性的性功能障碍
ES2477868T3 (es) 2005-04-22 2014-07-18 Alantos Pharmaceuticals Holding, Inc. Inhibidores de dipeptidil peptidasa-IV
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
KR20220061258A (ko) 2010-06-16 2022-05-12 앙도르쉐르슈 인코포레이티드 에스트로겐-관련 질병의 치료 또는 예방 방법
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
RU2733741C2 (ru) * 2015-05-29 2020-10-06 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Тетразамещенные алкеновые соединения и их применение
SI3355884T1 (sl) 2015-10-01 2021-11-30 Olema Pharmaceuticals, Inc. Antiestrogenska zdravila tetrahidro-1H-pirido(3,4-b)indola
MX373946B (es) 2015-12-09 2020-07-13 Univ Illinois Reguladores a la baja del receptor de estrogeno selectivo de benzotiofeno.
KR102111792B1 (ko) * 2016-03-25 2020-05-18 뤄신 바이오테크놀러지 (상하이) 컴퍼니 리미티드 에스트로겐 수용체 하향 조절제로서의 치환된 인돌 화합물
ES2990061T3 (es) 2016-05-10 2024-11-28 C4 Therapeutics Inc Degronímeros espirocíclicos para la degradación de proteínas diana
CN109641874A (zh) 2016-05-10 2019-04-16 C4医药公司 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
EP3454856B1 (en) 2016-05-10 2024-09-11 C4 Therapeutics, Inc. Heterocyclic degronimers for target protein degradation
WO2017197051A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Amine-linked c3-glutarimide degronimers for target protein degradation
AU2017290748A1 (en) 2016-07-01 2019-01-17 G1 Therapeutics, Inc. Pyrimidine-based antiproliferative agents
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
KR102425785B1 (ko) 2016-11-28 2022-07-28 에자이 알앤드디 매니지먼트 가부시키가이샤 인다졸 유도체의 염 및 이의 결정
AR110728A1 (es) 2017-01-06 2019-04-24 G1 Therapeutics Inc Terapia combinada para el tratamiento del cáncer
WO2018148576A1 (en) 2017-02-10 2018-08-16 G1 Therapeutics, Inc. Benzothiophene estrogen receptor modulators
EP3641762A4 (en) 2017-06-20 2021-03-10 C4 Therapeutics, Inc. N / O-LINKED DEGRONES AND DEGRONIMERS FOR PROTEIN DEGRADATION
CA3067873A1 (en) 2017-06-29 2019-01-03 G1 Therapeutics, Inc. Morphic forms of g1t38 and methods of manufacture thereof
EP3897631A4 (en) 2018-12-20 2022-11-23 C4 Therapeutics, Inc. TARGETED PROTEIN BREAKDOWN
CN114302722A (zh) 2019-07-07 2022-04-08 奥列马制药公司 雌激素受体拮抗剂方案
MX2022000520A (es) 2019-07-22 2022-02-10 Radius Pharmaceuticals Inc Compuestos moduladores del receptor de estrogeno.
CN118459468A (zh) 2019-12-20 2024-08-09 C4医药公司 用于egfr降解的异吲哚啉酮和吲唑化合物
EP4114392A4 (en) 2020-03-05 2024-04-10 C4 Therapeutics, Inc. Compounds for targeted degradation of brd9
WO2022032026A1 (en) 2020-08-05 2022-02-10 C4 Therapeutics, Inc. Compounds for targeted degradation of ret
EP4351583A4 (en) 2021-06-08 2025-06-04 C4 Therapeutics, Inc. THERAPEUTICS TO DEGRADE MUTANT BRAF
KR20250055538A (ko) 2022-08-03 2025-04-24 브리스톨-마이어스 스큅 컴퍼니 Ret 단백질을 조정하기 위한 화합물
JP2025540906A (ja) 2022-11-04 2025-12-17 ブリストル－マイヤーズ スクイブ カンパニー Ｒｅｔ－ｌｄｄタンパク質阻害剤
KR20250117789A (ko) 2022-11-04 2025-08-05 브리스톨-마이어스 스큅 컴퍼니 Ret-ldd 단백질 분해제
WO2025006753A2 (en) 2023-06-30 2025-01-02 Merck Patent Gmbh Heterobifunctional compounds for the degradation of kras protein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3232968A1 (de) * 1981-09-10 1983-06-09 Degussa Ag, 6000 Frankfurt Neue 2-(hydroxy-phenyl)-indole und verfahren zu deren herstellung
DE3821148A1 (de) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
GB9108811D0 (en) * 1991-04-24 1991-06-12 Erba Carlo Spa N-imidazolyl derivatives of substituted indole
RU2061694C1 (ru) * 1991-09-11 1996-06-10 Е.Р.Сквибб энд Санз, Инк., Производные индола
FR2708605A1 (fr) * 1993-07-30 1995-02-10 Sanofi Sa Dérivés du N-sulfonylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
CA2135160A1 (en) * 1992-05-08 1993-11-25 Masatoshi Inai Indole derivative
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
DE69504637T2 (de) * 1994-02-22 1999-05-06 Merrell Pharmaceuticals Inc., Cincinnati, Ohio Indolderivate zur behandlung von östrogenabhängigen neoplasmen und krankheiten
DE4426625A1 (de) * 1994-07-27 1996-03-14 Schering Ag 2-Phenylindole, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln

Also Published As

Publication number Publication date
UA47413C2 (uk) 2002-07-15
PT802184E (pt) 2002-09-30
JPH1036347A (ja) 1998-02-10
EA000815B1 (ru) 2000-04-24
EP0802184B1 (en) 2002-06-19
HK1002862A1 (en) 1998-09-25
CO4950540A1 (es) 2000-09-01
SK282765B6 (sk) 2002-12-03
DE69713441D1 (de) 2002-07-25
CN1103756C (zh) 2003-03-26
BR9701879A (pt) 1998-09-29
KR970069986A (ko) 1997-11-07
TW397821B (en) 2000-07-11
HU9700779D0 (en) 1997-06-30
NO308214B1 (no) 2000-08-14
CN1168373A (zh) 1997-12-24
EA199700043A1 (ru) 1997-12-30
CZ293065B6 (cs) 2004-02-18
HUP9700779A1 (hu) 1999-09-28
AU718888B2 (en) 2000-04-20
ATE219485T1 (de) 2002-07-15
NZ314595A (en) 2000-04-28
DK0802184T3 (da) 2002-09-16
ES2179273T3 (es) 2003-01-16
IL120699A0 (en) 1997-08-14
NO971814L (no) 1997-10-20
AR006705A1 (es) 1999-09-08
DE69713441T2 (de) 2002-11-07
AU1892197A (en) 1997-10-23
EP0802184A1 (en) 1997-10-22
SK47197A3 (en) 1997-11-05
NO971814D0 (no) 1997-04-18
CZ117697A3 (en) 1997-12-17

Similar Documents

Publication Publication Date Title
ID16618A (id) Bahan-bahan estrogen
CY2009016I1 (el) Οιστρογονοι παραγοντες
DE69703675D1 (de) Zementhaltiges Material
ATE208395T1 (de) Thiophenopyrimidine
PT938496E (pt) Misturas insecticidas sinergicas
ATE262512T1 (de) Arylalkanoylpyridazine
ID18880A (id) Kopolimer propilena-1-butena
ATE208773T1 (de) Chinoxalindione
ID15959A (id) Bahan pembungkus
FI972210A0 (fi) Icke-svettdrivande material
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
ID16973A (id) Bahan pewarna piridon
DE69705820D1 (de) Laseroszillator
BR9711681A (pt) Novos m-todos
ID16604A (id) Bahan-bahan estrogen
NO964439D0 (no) For
FI962614A0 (fi) Foerfarande foer belaeggning av styra kroppar av luftgenomslaeppligt material
FI962706A0 (fi) Anordningar foer separering av fast material fraon vaetska
FI962861A0 (fi) Anordningar foer avskiljning av fast material fraon vaetska
SE9602173D0 (sv) Representationskort
FI2492U1 (fi) Lista
KR970050198U (ko) 개량감지기
NO960756D0 (no) For
BR9600867A (pt) Conjunto empacotadora-enfardadora
SE9600873D0 (sv) Aktiverare